Neuroscience is the Next Oncology

| April 1, 2018 | 0 Comments

by Michael D. Ehlers, MD, PhD

Dr. Ehlers is with Biogen in Cambridge, Massachusetts.

Innov Clin Neurosci. 2018;15(3–4):15–16

Funding: No funding was received for the preparation of this article.

Disclosures: Dr. Ehlers is an employee and shareholder at Biogen Inc. in Cambridge, Massachusetts.

Category: Commentary, Past Articles, Trial Methodology

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.